Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

CURRENT APPROACH ON CUTANEOUS MELANOMA DIAGNOSTICS

View through CrossRef
Melanoma is on the first place in mortality among all skin tumors. Over the past 50 years, there has been a steady increase in the incidence of cutaneous melanoma compared to other types of tumors. Rates of 5-year survival are fairly high, if melanoma is diagnosed in the early stages, which requires adequate diagnostics and treatment. Melanoma diagnostic, especially in the early stages, can be problematic even for an experienced dermatologist. However, primary contact doctor can be any specialty. Melanoma and other skin tumors can be detected by physical examination during treatment for another disease. Phenotypic risks factors, anamnestic data, and physical examination data are important in cutaneous melanoma diagnostics. The sensitivity of clinical diagnosis during a visual examination by an experienced dermatologist is approximately 70 percent. However, dermascopy can significantly increase the accuracy of a clinical diagnostics. In recent years there has been an active research for new non-invasive methods and algorithms for cutaneous melanoma diagnostics. The main goal of non-invasive diagnostics is to determine need for biopsy. This decision should be based on a combination of clinical and dermascopic examinations and other information, including growth dynamics, symptoms and medical history. Thus, an adequate diagnostic of cutaneous melanoma, including non-invasive and invasive methods, is a simple and economically viable way to early detection of cutaneous melanoma and to reduce mortality from this aggressive disease.
Autonomous non-profit scientific and medical organization - Questions of Oncology
Title: CURRENT APPROACH ON CUTANEOUS MELANOMA DIAGNOSTICS
Description:
Melanoma is on the first place in mortality among all skin tumors.
Over the past 50 years, there has been a steady increase in the incidence of cutaneous melanoma compared to other types of tumors.
Rates of 5-year survival are fairly high, if melanoma is diagnosed in the early stages, which requires adequate diagnostics and treatment.
Melanoma diagnostic, especially in the early stages, can be problematic even for an experienced dermatologist.
However, primary contact doctor can be any specialty.
Melanoma and other skin tumors can be detected by physical examination during treatment for another disease.
Phenotypic risks factors, anamnestic data, and physical examination data are important in cutaneous melanoma diagnostics.
The sensitivity of clinical diagnosis during a visual examination by an experienced dermatologist is approximately 70 percent.
However, dermascopy can significantly increase the accuracy of a clinical diagnostics.
In recent years there has been an active research for new non-invasive methods and algorithms for cutaneous melanoma diagnostics.
The main goal of non-invasive diagnostics is to determine need for biopsy.
This decision should be based on a combination of clinical and dermascopic examinations and other information, including growth dynamics, symptoms and medical history.
Thus, an adequate diagnostic of cutaneous melanoma, including non-invasive and invasive methods, is a simple and economically viable way to early detection of cutaneous melanoma and to reduce mortality from this aggressive disease.

Related Results

Causal relationship between atrial fibrillation/warfarin and cutaneous melanoma: a two-sample Mendelian randomization study
Causal relationship between atrial fibrillation/warfarin and cutaneous melanoma: a two-sample Mendelian randomization study
PurposeIn recent years, the relationship between malignant tumors and atrial fibrillation has attracted more and more attention. Atrial fibrillation can also cause a series of adve...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Background Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus erythematosus) and non-s...
The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma
The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma
Abstract: Cutaneous melanoma can lead to metastasis, and it is associated with high mortality. Currently, there are no widely accepted immunohistochemistry markers for me...
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract Several lines of experimental evidence have demonstrated the importance of the tumor microenvironment in controlling melanoma tumor growth and melanoma meta...
Abstract 1275: Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma
Abstract 1275: Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma
Abstract BACKGROUND: The identification of proteins responsible for tumor development and regulation is of great value. In this study, we aimed to identify novel fun...
YY1-induced lncRNA00511 promotes melanoma progression via the miR-150- 5p/ADAM19 axis
YY1-induced lncRNA00511 promotes melanoma progression via the miR-150- 5p/ADAM19 axis
Abstract Background Long noncoding RNAs (lncRNAs) are key regulators of oncogenic processes, and one such lncRNA is lncRNA511 (LINC00511), which is associated with breast,...

Back to Top